Race Oncology Ltd. (AU:RAC) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Race Oncology Ltd has released a video recording of its 2024 Annual General Meeting, highlighting their progress in advancing bisantrene, a promising chemotherapeutic with reduced cardiotoxicity. The company is actively exploring partnerships to expand global access to its treatments and address unmet needs in cancer care. Investors are encouraged to access the AGM video for detailed insights into Race’s strategic plans and collaborations.
For further insights into AU:RAC stock, check out TipRanks’ Stock Analysis page.